Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cupressus arizonica allergen 1 (Cup a 1) is the primary pectate lyase allergen found in the pollen of the Arizona cypress, a major cause of winter pollinosis in Mediterranean and semi-arid regions (UniProt P80174, IUIS Allergen Nomenclature). The target "Cup a 1 – IgE on mast cells/basophils" describes the functional complex formed when Cup a 1 molecules cross-link specific IgE antibodies that are anchored to the high-affinity IgE receptor (FcεRI) on the surface of mast cells and basophils (PubMed PMID: 7522144). This cross-linking event triggers a signal transduction cascade leading to the degranulation of these effector cells and the subsequent release of inflammatory mediators like histamine, which drive the clinical symptoms of allergic rhinitis and asthma (Janeway's Immunobiology). This complex is a focal point for therapeutic intervention; for instance, omalizumab acts by sequestering free IgE to prevent its binding to FcεRI, thereby reducing the density of the complex on cell surfaces (PubMed PMID: 25697467). Additionally, allergen-specific immunotherapy (AIT) utilizes Cup a 1 extracts to desensitize the immune system, promoting the production of IgG4 blocking antibodies and regulatory T cells to inhibit this specific IgE-mediated pathway (PubMed PMID: 30033913).
Inhibition of IgE-FcεRI interaction and induction of allergen-specific immune tolerance.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cupressus arizonica allergen 1 (Cup a 1) - Immunoglobulin E (IgE) - High affinity immunoglobulin epsilon receptor (FcεRI) complex (Cup a 1-IgE-FcεRI).